申请人:Guangzhou Institute Of Biomedicine And Health,
Chinese Academy Of Sciences
公开号:EP2314588A1
公开(公告)日:2011-04-27
The compounds according to formula (I), their pharmaceutically acceptable acid or base addition salts, and the uses thereof. These compounds and their pharmaceutically acceptable acid or base addition salts can be used for preparing medicaments for modulating estrogen related receptors (ERR), and treating metabolic diseases, such as high blood fat, fatty liver, hyperglycemia, diabetes, obesity. The substituents of the formula are defined in the description.
根据式(I)的化合物、其药学上可接受的酸或碱加成盐及其用途。这些化合物及其药学上可接受的酸或碱加成盐可用于制备调节雌激素相关受体(ERR)和治疗代谢性疾病(如高血脂、脂肪肝、高血糖、糖尿病、肥胖症)的药物。式中取代基的定义见说明。